Patents by Inventor Mordechai Farbstein

Mordechai Farbstein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Medical device having a valve for autoclavability
    Patent number: 11903568
    Abstract: A medical device with a valve for autoclavability is disclosed. The medical device may include a cavity. A channel connects the cavity to an autoclave environment. The channel has a distal end and proximal end. The distal end of the channel may open to the autoclave environment and the proximal end may open to the cavity. A valve may be positioned in or near the channel. The valve may permit gas to flow from the cavity when a pressure inside the cavity is greater than a pressure in the autoclave environment outside the cavity. The valve may also prevent gas from flowing into the cavity when the pressure in the autoclave environment outside the cavity is greater than the pressure inside the cavity.
    Type: Grant
    Filed: February 9, 2022
    Date of Patent: February 20, 2024
    Assignee: DENTAL SMARTMIRROR, INC.
    Inventors: Gidon Oded Elazar, Dan Zidkiahu Harkabi, Omri Mordechai Farbstein
  • MEDICAL DEVICE HAVING A VALVE FOR AUTOCLAVABILITY
    Publication number: 20230101078
    Abstract: A medical device with a valve for autoclavability is disclosed. The medical device may include a cavity. A channel connects the cavity to an autoclave environment. The channel has a distal end and proximal end. The distal end of the channel may open to the autoclave environment and the proximal end may open to the cavity. A valve may be positioned in or near the channel. The valve may permit gas to flow from the cavity when a pressure inside the cavity is greater than a pressure in the autoclave environment outside the cavity. The valve may also prevent gas from flowing into the cavity when the pressure in the autoclave environment outside the cavity is greater than the pressure inside the cavity.
    Type: Application
    Filed: February 9, 2022
    Publication date: March 30, 2023
    Applicant: DENTAL SMARTMIRROR, INC.
    Inventors: Gidon Oded ELAZAR, Dan Zidkiahu HARKABI, Omri Mordechai FARBSTEIN
  • Medical device having a valve for autoclavability
    Patent number: 11278198
    Abstract: A medical device with a valve for autoclavability is disclosed. The medical device may include a cavity. A channel connects the cavity to an autoclave environment. The channel has a distal end and proximal end. The distal end of the channel may open to the autoclave environment and the proximal end may open to the cavity. A valve may be positioned in or near the channel. The valve may permit gas to flow from the cavity when a pressure inside the cavity is greater than a pressure in the autoclave environment outside the cavity. The valve may also prevent gas from flowing into the cavity when the pressure in the autoclave environment outside the cavity is greater than the pressure inside the cavity.
    Type: Grant
    Filed: July 9, 2021
    Date of Patent: March 22, 2022
    Assignee: Dental SmartMirror, Inc.
    Inventors: Gidon Oded Elazar, Dan Zidkiahu Harkabi, Omri Mordechai Farbstein
  • A3 adenoside receptor agonists for the reduction of intraocular pressure
    Patent number: 8557790
    Abstract: The present disclosure provides the use of an A3R agonist, such as IB-MECA, for reducing in a subject, preferably, human subject, intra ocular pressure (IOP). Similarly, the invention provides a pharmaceutical composition and a method for reducing IOP in a subject making use of the A3R agonist.
    Type: Grant
    Filed: May 16, 2010
    Date of Patent: October 15, 2013
    Assignee: Can-Fite Biopharma Ltd.
    Inventors: Pnina Fishman, Mordechai Farbstein
  • A3 ADENOSIDE RECEPTOR AGONISTS FOR THE REDUCTION OF INTRAOCULAR PRESSURE
    Publication number: 20120065155
    Abstract: The present disclosure provides the use of an A3R agonist, such as IB-MECA, for reducing in a subject, preferably, human subject, intra ocular pressure (IOP). Similarly, the invention provides a pharmaceutical composition and a method for reducing IOP in a subject making use of the A3R agonist.
    Type: Application
    Filed: May 16, 2010
    Publication date: March 15, 2012
    Applicant: CAN-FITE BIOPHARMA LTD.
    Inventors: Pnina Fishman, Mordechai Farbstein